Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1996; 75(05): 859-860
DOI: 10.1055/s-0038-1650381
DOI: 10.1055/s-0038-1650381
Letter to the Editor
Factor V Leiden and Sickle Cell Disease
Further Information
Publication History
Received 08 December 1995
Accepted after revision 30 January 1996
Publication Date:
10 July 2018 (online)
-
References
- 1 Takamiya O, Ishida F, Kodaira H, Kitano K. APC-resistance and Mnl I genotype (Gin 506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996
- 2 Fujimara H, Kambayashi J, Monden M, Kato H, Miyata T. Coagulation Factor V Leiden mutation may have a racial background. Thromb Haemost 1995; 74: 1381-1382
- 3 Francis Jr RB. Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion. Blood Coagul Fibrinolysis 1991; 2: 341-353
- 4 Dahlbäck B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Intern Med 1995; 237: 221-227
- 5 Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
- 6 Rees C, Cox M, Clegg J. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134